8-K: Sanuwave Health and SEP Acquisition Corp. Extend Merger Deadline to June 30th, Sanuwave Gains Termination Right

Sanuwave Health and SEP Acquisition Corp. have extended the deadline for their merger agreement to June 30, 2024, and Sanuwave now has the unilateral right to terminate the agreement.

Summary

• Sanuwave Health, Inc. and SEP Acquisition Corp. have amended their merger agreement, extending the deadline for completion to June 30, 2024.
• The original merger agreement was dated August 23, 2023.
• This is the third amendment to the agreement.
• The amendment also grants Sanuwave the right to terminate the agreement at any time with written notice to SEP Acquisition Corp.
• No other changes were made to the original merger agreement.

Sentiment

Score: 4

Explanation: The sentiment is somewhat negative due to the extension of the merger deadline and the addition of a termination clause for Sanuwave, indicating potential issues with the deal's completion. The language is neutral but the actions suggest uncertainty.

Positives

• Sanuwave has gained the flexibility to terminate the merger agreement if it chooses to do so.

Risks

• The merger may still not be completed by the new deadline of June 30, 2024.
• The merger agreement could be terminated by Sanuwave at any time.
• The transaction is dependent on SEP Acquisition Corp. having at least $12 million at closing from stock and private placement proceeds.
• There are risks related to obtaining regulatory approvals and maintaining the listing of SEP Acquisition Corp.'s securities on Nasdaq.

Future Outlook

The document includes forward-looking statements regarding the completion of the merger, but cautions that actual results may differ due to various risks and uncertainties. The companies do not commit to updating these statements.

Management Comments

• The parties have agreed to further amend the Merger Agreement on the terms set forth herein.
• The Merger Agreement shall remain in full force and effect except as provided in this Amendment.

Industry Context

This announcement is related to a specific merger transaction and does not provide significant insight into broader industry trends. However, it highlights the complexities and potential delays that can occur in merger and acquisition processes.

Comparison to Industry Standards

• Merger agreements often include outside dates and termination clauses, which are standard practice in M&A transactions.
• The extension of the outside date and the addition of a unilateral termination right for Sanuwave are not uncommon when there are delays or changes in circumstances.
• The $12 million minimum cash requirement for SEP Acquisition Corp. is a specific condition of this merger and is not a general industry standard.

Stakeholder Impact

• Shareholders of Sanuwave face uncertainty regarding the completion of the merger.
• Employees of both companies may experience uncertainty about their future roles.
• The merger's success is important for the future of both companies.

Next Steps

• The companies need to satisfy all conditions to close the merger by June 30, 2024.
• SEP Acquisition Corp. needs to secure at least $12 million in funding.
• Sanuwave has the option to terminate the agreement at any time.

Key Dates

Keywords

Merger Agreement, Sanuwave Health, SEP Acquisition Corp, Merger, Amendment, Termination, Outside Date